Publication | Closed Access

High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success

UrologyMedicineCancer ManagementBrachytherapyEarly Biochemical PredictorsOncologyRadiation OncologyLong-term OutcomesDifferent Treatment Schedules